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Helminths are master regulators of host immune responses utilising complex mechanisms to dampen host protective Th2-type
responses and favour long-term persistence. Such evasion mechanisms ensure mutual survival of both the parasite and the host.
In this paper, we present recent ﬁndings on the cells that are targeted by helminths and the molecules and mechanisms that are
induced during infection. We discuss the impact of these factors on the host response as well as their eﬀect in preventing the
development of aberrant allergic inﬂammation. We also examine recent ﬁndings on helminth-derived molecules that can be used
as tools to pinpoint the underlying mechanisms of immune regulation or to determine new anti-inﬂammatory therapeutics.
1.Introduction: Features of Helminth-Induced
ImmuneResponses
Helminths have developed a unique evolutionary dialogue
with their hosts’ immune system due to their longevity with-
in the host, their complex life cycles, and multicellular na-
ture. These pathogens induce very diﬀerent immune re-
sponses in comparison to bacteria, fungi, viruses, or proto-
zoa. Cells of the innate and adaptive immune system are im-
portant for the initiation of type 2 immunity, which charac-
terises the response to helminth infection, as well as allergic
reactions. The key players in T helper (Th) 2-type immunity
are CD4+ Th2 cells and involve the cytokines interleukin
(IL-)4, IL-5, IL-9, IL-10, and IL-13 and immunoglobulin
(Ig)E. CD4+ Th2 cells also express some of the cytokines
mentioned above as well as the chemokine ligand CCL11
and the chemokine receptor CCR3 [1–3]. These factors lead
to recruitment and inﬁltration of eosinophils, basophils
and mast cells, and expansion of alternatively activated ma-
crophages [4]. Notably, Th2-type immune responses are
composed of three major features: inﬂammation, wound
repair, and, most importantly, resistance to helminths.
P a r a s i t e sh a v ed e v e l o p e dv a r i o u ss t r a t e g i e st om o d u l a t e
the immune system and ultimately suppress host protective
Th2-type immune responses for example, by induction of
innate and adaptive regulatory cells, anti-inﬂammatory cy-
tokines and speciﬁc inhibitory antibody isotypes (reviewed
by Anthony et al. [2]).
Hence, helminth parasites are master regulators of im-
mune responses in order to ensure life-long persistence in
the host. One strategyofimmune regulation thathas evolved
is the secretion of a wide range of immunoregulatory mole-
cules, which are able to target various host cells and alter
them to induce a highly directed host response known as a
“modiﬁed Th2-type response.” This response is designed to
limit a possibly detrimental Th2 immune response, thus re-
straining the extreme symptoms that are often observed in
allergy or in aspects of helminth diseases such as ﬁbrosis in
Schistosoma mansoni [3]. In immunological terms, the mod-
iﬁed Th2 response is deﬁned by the development of speciﬁc
antibody isotypes, including induction of IgG4 accompanied
by a decrease in IgE, as well as IL-4 and IL-5, while IL-
10 levels from diﬀerent regulatory cell sources increase [5].
These mechanisms can lead to attenuation of pathology
and clinical symptoms, tolerance, and ultimately persistence
of the worm, which is associated with a hyporesponsive
immune system. Asymptomatic infection assures long-term
survival of the parasite within the host and therefore sustains
parasite feeding, completion of the life cycle, and successful
reproduction [3, 5].2 Journal of Biomedicine and Biotechnology
Many studies of animal and human helminth infections
have shown their potential for downregulating the immune
system. Moreover, relevant epidemiological studies have
observed that helminth-infected populations exhibit lower
levels of immunopathological diseases such as Th1-related
autoimmune diseases or abberrant Th2-related diseases for
example,asthmaorallergicrhinitis.Theseobservationsindi-
cate an inverse global distribution of allergy/autoimmune
diseases and helminth infections, the ﬁrst being an expand-
ing problem of developed and industrialized countries, while
the latter being a feature in developing countries [6–9]. Such
ﬁndings support the hypothesis that the immune system has
coevolved to operate in the presence of immunomodulatory
helminth infections, while in the absence of exposure to
helminths, the immunoregulatory components that would
normally prevent allergy and autoimmune disease become
weakened [5, 10].
Here,wefocusonrecentadvancesincellularmechanisms
that are employed and modulated during helminth infec-
tions as well as on reports from ﬁeld research and studies
on animal models. These studies have identiﬁed helminths
and helminth-derived products that play a role either in
induction of Th2 responses and immune modulation in
parasitic infections (reviewed in Table 1) or in downregula-
tion of bystander Th2-type immunopathologies like allergic
asthma, allergic inﬂammation and airway hyperreactivity,
food allergy, eczema, atopic dermatitis (Th1/Th2), or ana-
phylaxis (reviewed in Table 2).
2. Epidemiological Evidence of
Helminth-InducedImmunoregulation
2.1. Immunoregulation during Helminth Infection in Humans.
It has long been known that helminths induce a speciﬁc
immunephenotypeinthemajorityofpersonsthatallowsfor
establishment of infection while simultaneously preventing
or reducing signs of disease in the host [11]. Antigen-
speciﬁc cellular hyporesponsiveness was described for ﬁlarial
infections more than 30 years ago by Ottesen et al. studying
a population in the Cook Islands endemic for lymphatic
ﬁlariasis. Inthis study lymphocytesfromadultsinfectedwith
the ﬁlarial species Wuchereria bancrofti showed signiﬁcantly
lower levels of proliferation in response to ﬁlarial antigen
compared with endemic controls who were negative for
all signs of infection or disease but constantly exposed to
infection and, therefore, putatively consistently exposed to
the antigens [12]. Later, another study from the same group
made the distinction between microﬁlariae (mf) positive
asymptomatically infected persons and mf negative patients
showing clinical symptoms of ﬁlariasis (e.g., elephantiasis
or hydrocoele) [13]. The resulting data suggested that the
outcome of disease depends on the host response together
with a mechanism of immune modulation induced by the
parasite (reviewed by Ottesen [14]). Epidemiological studies
of helminth-infected persons recognise distinct clinical out-
comes that depend on immune regulation induced by the
parasite in conjunction with the genetic background of the
host (reviewed by Maizels and Yazdanbakhsh [3]). Resistant
individuals are constantly exposed to the parasite but show
no signs of infection or disease; this group develops an ap-
propriate response, deﬁned by equal proportions of Th1,
Th2, and T regulatory (Treg) cells with a balance of IgG4
and IgE levels. A second group develops a hyporesponsive
phenotype characterised by asymptomatic infection, which
tolerates the presence of fecund adult worms. This group has
high levels of regulatory cells and IL-10, leading to a mod-
iﬁed Th2 response. Finally, a small proportion of patients
develops a hyperresponsive phenotype (characterised by an
immunopathological response) [3, 11, 14]. In S. mansoni, W.
bancrofti,a n dBrugia malayi infections, the main patholog-
ical response is a result of overreactive T cell responses that
cause inﬂammation and injure the host. This group exhibits
increased IgE responses, and the Treg compartment is greatly
diminished. In W. bancrofti and B. malayi infections, this can
resultinelephantiasis,wherebythelymphatictissuebecomes
dilated and hypertrophic. Parasite death leads to the release
of antigenic material that causes lymphatic obstruction in
the vessels and chronic inﬂammation [14]. A second, rare
result of these infections is tropical pulmonary eosinophilia
characterised by chronic lung obstruction, peripheral blood
eosinophilia, and extremely elevated levels of IgE, greater
than in elephantiasis [15]. In Onchocerca volvulus infection
the rare chronic hyperreactive form, known as Sowda, is also
deﬁned by high levels of IgE [16]. This is accompanied by
strong Th2 responses, including IL-4, IL-5, and IL-13. Thus
a ﬁne balance of diﬀerent aspects of immunity is required to
develop a response beneﬁcial to the host.
Therefore, immune modulation acts in favour of persis-
tent infection and continuous transmission while simultane-
ously enabling the host to tolerate infection by diminishing
clinical symptoms. Coinfection studies of helminths with
other diseases provide supporting evidence that helminths
have great ability to modulate immune responses, some
aspectsofwhichmaythenaﬀectbystanderinfections.Infact,
protective inﬂammatory immune responses that typically
develop in bacterial or intracellular parasitic infections can
be downregulated when a coinfecting helminth is present,
resulting in increased susceptibility in the host to the
former infection. For example, individuals coinfected with
latent tuberculosis (TB) and W. bancrofti showed lower lev-
els of TB-protective proinﬂammatory cytokines in vitro than
TB patients without ﬁlarial infection. This eﬀect was re-
versed after treatment with microﬁlaricidal drugs [47]. Re-
search focusing on individuals coinfected with multiple
ﬁlarial species and Plasmodium falciparum demonstrated
a modulation of the antimalarial immune response by
helminths that increased anti-inﬂammatory responses [48].
After stimulation with malaria antigen, ﬁlarial-infected indi-
viduals demonstrated signiﬁcantly lower levels of interferon
(IFN)-γ, tumour necrosis factor (TNF)-α and IL-17A, and
higher levels of IL-10 from CD4+ T cells compared with
ﬁlarial-uninfected individuals. Similarly, a study examining
the eﬀect of helminth infections on responses to oral cholera
vaccine demonstrated that Ascaris lumbricoides infection was
associated with lower cholera antigen-speciﬁc IL-2 cytokine
responses [49]. These epidemiological studies demonstrate
the ability of helminths to modulate immune responses to
themselves as well as to concurring and unrelated infections.Journal of Biomedicine and Biotechnology 3
Table 1: Helminth-derived immunomodulatory and Th2-inducing molecules. CXCL: chemokine ligand; DC: dendritic cell; Ig:
immunoglobulin; GI: gastrointestinal; IFN-γ: interferon gamma; IL: interleukin; LPS: lipopolysaccharide; MAP: mitogen activated kinase;
MHC: major histocompatibility complex; MIF: macrophage migration inhibitory factor; PBMC: peripheral blood mononuclear cell; STAT:
signal transducer and activator of transcription; TGF: transforming growth factor; Th: T helper cell; TLR: Toll-like receptor; Treg: T
regulatory cell.
Helminth species Name Molecule Mechanisms of immune modulation during
infection Reference
Echinococcus
granulosus AgB Antigen B Reduces expression of costimulatory molecules on
human DCs and induces Th2 [17]
Fasciola hepatica FheCL1 Cysteine protease Prevents release of macrophage inﬂammatory
mediators by degrading TLR3 [18]
Schistosoma mansoni
Lyso-PS Lyso-phosphatidylserine Lyso-PS treated DCs induce IL-10+ Treg through
TLR2 and promote Th2 polarization [19, 20]
DsRNA Double-stranded RNA Triggers TLR3 to activate STAT1 and induces
expression of type 1 IFNs in DCs [21, 22]
Omega-1 Ribonuclease
Reduces expression of costimulatory molecules and
IL-12 in DCs and induces IL-4 and Foxp3 in CD4+
cells
[23–25]
IPSE/alpha-1 Glycoprotein Induces IgE-dependent IL-4 production from
basophils in vivo [26]
SmCKBP Chemokine-binding
protein
Suppresses neutrophil recruitment by inhibiting the
mammalian chemokine CXCL8 [27]
Ascaris suum PAS-1 200kDa protein Suppresses proinﬂammatory cytokines and
neutrophil inﬂux after exposure to LPS [28]
Necator americanus
Na-ASP-2 High homology to C-C
chemokines
Secreted by infective larvae, recruits neutrophils in
vitro and in vivo [29]
Na-NES Metalloprotease Cleaves the eosinophil chemoattractant CCL11 and
prevents its action in vitro and in vivo [30]
Nippostrongylus
brasiliensis Acetylhydrolase Acetylhydrolase Inactivates mammalian platelet-activating factor,
thus potentially regulating GI inﬂammation [31]
Trichinella spiralis Ts-MIF MIF homologue Inhibits migration of human PBMCs, similar to
human MIF [32]
Trichuris muris 43kDa IFN-γ
homologue IFN-γ homologue Binds to IFN-γ receptor in mice [33]
Acanthocheilonema
viteae
AvCystatin /Av17 Cysteine protease
inhibitor
Downregulates T cell responses. Interferes with
macrophage MAP kinase signaling pathways to
induce IL-10
[34, 35]
ES-62
Phosphorylcholine-
containing
glycoprotein
Reduces CD4+ T cell proliferation and IL-2
production, inhibits IL-4 and IL-13 production
Inhibits IL-12 production from macrophages after
exposure to LPS in a TLR4-dependent manner
Induces an anti-inﬂammatory phenotype in DCs
[36–39]
Brugia malayi
Bm-ALT-1,
Bm-ALT-2
Abundant larval
transcript proteins
Expression of Bm-ALT in recombinant Leishmania
mexicana parasites diminishes IFN-γ-mediated
killing and induces GATA-3 and SOCS-1 in these
macrophages
[40]
Bm-CPI-2 Cysteine protease
inhibitor
Blocks antigen presentation via MHC class II by
interfering with asparaginyl endopeptidase [41, 42]
Bm-TGH-2 Homologue of TGF-β Binds to mammalian TGF-β receptors thus
potentially inﬂuencing Treg diﬀerentiation [43]
Litomosoides
sigmodontis Ls-cystatin Cysteine protease
inhibitor Reduces antigen-speciﬁc proliferation of spleen cells [44]
Onchocerca volvulus Onchocystatin Cysteine protease
inhibitor
Suppresses antigen-speciﬁc proliferation of PBMCs,
induces IL-10 from stimulated PBMCs
Reduces expression of MHC class II molecules and
CD86 on human monocytes
[45, 46]4 Journal of Biomedicine and Biotechnology
Table 2: Eﬀects of helminth infections and helminth-derived products/molecules on improvement of symptoms in allergy-related
experimental animal models.
Allergy model Suppressive mechanism Reference
Deﬁned helminth molecules; (from helminth species)
smCKBP; (S. mansoni) Hapten-induced contact
hypersensitivity NA3 [27]
Sm22.6, PIII and Sm29; (S.
mansoni) OVA-induced AI1 CD4+Foxp3+ Treg [65]
As-MIF; (A. simplex) OVA-induced AI IL-10, TGF-β, and Treg dependent [66]
PAS-1; (A. suum) APAS-3-induced AI Possibly IL-10 [67]
OVA-induced AHR2 CD4+CD25+ Tc e l l - ,C D 8 + T cell-dependent and
IL-10/TGF-β-, IFN-γ-mediated [68, 69]
Nippocystatin (NbCys); (N.
brasiliensis) OVA-induced AI Cathepsin B and cathepsin L-dependent mechanism [70]
AvCystatin (Av17); (A. viteae) OVA-induced AHR IL-10, macrophages, partially CD4+CD25+ Tc e l l s [ 71]
ES-62; (A. viteae)
Oxazolone- (Oxa-) induced skin
immediate hypersensitivity
OVA-induced AHR
Mast cell mediated, TLR4-dependent [72]
Helminth infection and undeﬁned products
S. mansoni infection; males and
females + eggs laid in infection;
males (no eggs)
Pen V-induced systemic anaphylaxis IL-10-producing B cells [73]
S. mansoni infection; males (no
eggs) OVA-induced AHR B cell- and IL-10-dependent suppression of pulmonary
eosinophil inﬁltration [74]
S. mansoni infection; eggs OVA-induced AI Egg-treatment: CD4+CD25+Foxp3+Treg [75]
S. japonicum egg antigen (SEA) OVA-induced AI CD4+CD25+ Treg, possibly IL-10 [76]
A. suum adult worm extract
(ASC) OVA-induced AHR NA [77]
Heligmosomoides
polygyrus infection
OVA-induced AHR IL-10 [78]
OVA-induced AHR
HDM-induced AI
IL-10-independent, CD4+CD25+ Tc e l l s
IL-10-independent Breg cells [79, 80]
Peanut extract-induced food allergy IL-10 [81]
H. polygyrus excretory-secretory
product (HES) OVA-induced AI HES-induced Treg cells [82]
N. brasiliensis infection OVA-induced AHR IL-10 from unknown cell source [83]
N. brasiliensis excretory-secretory
product (NES) OVA-induced AI NA (IL-10 independent) [84]
Strongyloides stercoralis infection OVA-induced AI NA [85]
Strongyloides venezuelensis
infection OVA-induced AI NA [86]
T. spiralis infection OVA-induced AI Correlated with increased IL-10, TGF-β,C D 4 +CD25+
Treg [87]
L. sigmodontis infection OVA-induced AHR TGF-β,C D 4 +CD25+ Treg [88]
1(AI): airway inﬂammation, associated with inﬂammatory cell inﬂux into the lungs and local Th2 cytokine production.
2 (AHR): airway hyperreactivity, mainly described as lung bronchiole and smooth-muscle tissue remodelling leading to airﬂow obstruction, resultingi n
altered airway function. Chronic airway inﬂammation may lead to AHR, however, diﬀerent immunopathological pathways govern the regulation of AI and
AHR (discussed elsewhere [89–93]).
3NA data not available.
2.2.InverseCorrelationbetweenHelminthInfectionsandAller-
gicReactions. Eradicationofhelminthinfectionsinindustri-
alised countries in the past 30 years has had a great impact
on the prevalence of diseases associated with inappropriate
immune responses. The observed increase in the appearance
ofallergy-relateddiseasesmightbearesultofthisandaltered
hygienic measures in everyday life. One possible explanation
is the hygiene hypothesis [50, 51], which includes a number
of factors like improved public health, use of antibiotics and
vaccines that in consequence reduce the occurrence of viral,
bacterial or helminth infections early in life, contributing to
higher numbers of individuals with allergic, and/or autoim-
mune disorders.
There are numerous cohort studies determining allergic
disease status and immune responses to parasite-speciﬁc
antigens or environmental allergens of helminth-infectedJournal of Biomedicine and Biotechnology 5
individuals in parasite-endemic areas (reviewed by others
[6, 8]). However, when interpreting this data it is important
totakeintoconsiderationthetimeofﬁrstinfection,duration
and intensity of infection, helminth species, as well as host
genetic and environmental factors.
Infections with trematodes, whipworms and hookworms
were described to be negatively correlated with the allergen
skin prick test [52]. Results from a study of Gabonese school
children tested for skin reaction to house dust mites (HDMs)
and other allergens, for Schistosoma eggs in urine and micro-
ﬁlariae of Loa loa and Mansonella perstans in blood, showed
lower prevalence of a positive skin test to HDMs in chil-
dren with urinary schistosomiasis. Moreover, schistosome
antigen-speciﬁc concentrations of IL-10 were signiﬁcantly
higher in infected children and concentrations of IL-10 were
negatively associated with a positive skin test result [53].
Several population studies done in endemic areas of
Schistosoma i n f e c t i o n si nB r a z i l[ 54, 55]a n do fAscaris,
Trichuris,a n dAncylostoma in Ecuador [56] revealed a strong
inverse association between helminth infections and imme-
diate skin test reactivity to common environmental aeroal-
lergens. Araujo et al. [54]a n dC o o p e re ta l .[ 56]r e p o r t e d
a negative association between very high levels of IgE anti-
bodiesandallergenskintestreactivity.Itispossiblethatanti-
helminth-IgE competes for the same high-aﬃnity IgE recep-
tors targeted by allergen-speciﬁc IgE [54]. Although other
studiesfromAfricareportedonareverseassociationbetween
hookworminfectionsandsensitization toHDMDermatoph-
agoides pteronissinus (Der p 1), they did not show a signif-
icant association between skin test sensitivity to HDMs, al-
lergen-speciﬁc IgEs and between total serum IgE levels and
helminth-speciﬁc IgEs [57, 58].
The contribution of helminth infections to the inverse
correlation with allergy-related diseases was demonstrated
in studies with anthelminthic treatment. Results from a ran-
domized, controlled trial on the eﬀect of repeated treatment
with anthelminthics on a population of Gabonese school
children showed a signiﬁcant increase in the rate of devel-
oping skin sensitivity to HDMs. This was in part mediated
by reductions of Ascaris and/or Trichuris infections, directly
pointing to the importance of a presence of live worms to
suppress allergic responses during infection and also pre-
venting allergy later in life [59]. Lynch et al. also reported
an eﬀect of anthelminthic treatment on the allergic reactivity
of children in the tropics in Venezuela. The authors showed
that the eﬀective elimination of intestinal helminth infection
resulted in signiﬁcantly decreased total serum IgE levels.
However, immediate-hypersensitivity skin test reactivity and
serum levels of speciﬁc IgE antibody against common aller-
gens were signiﬁcantly increased in treated children [60].
Also other studies reported that anthelminthic treatments
increase allergen skin reactivity to environmental allergens
[61, 62]. Rodrigues et al. reported that Brazilian children
with heavy infection in early childhood with Trichuris trichi-
ura had a lower prevalence of allergen skin test reactivity to a
wide spectrum of common environmental allergens (HDMs,
Blomia tropicalis, fungi, animal, and cockroach allergens)
later in childhood, even when the helminth infection was
no longer present [63]. Additionally, a population study in
Taiwan showed that schoolchildren bearing pinworm Enter-
obiuswerediagnosedwithlowerprevalenceofasthmaandal-
lergic rhinitis; moreover, these children had reported an in-
fection of pinworms early on in life [64]. Thus, early expo-
sures and infections with helminths may have a protective
eﬀect and suppress allergic inﬂammation later during life.
Additionally, host genetic factors may play a role in prev-
alence of helminth infections and allergies. Notably variants
of genes involved in Th2 immune responses like IL13 or
STAT6 were associated with increased risk of asthma and al-
lergy[94–97].StudiesamongAfrican-Americansshedalight
on the limited understanding we have on asthma genetics.
Polymorphisms in candidate genes associated with asthma
showed higher frequency among certain ethnic backgrounds
that developed strong Th2 immune responses [6, 98, 99].
Thus, genes, which in the evolution of the immune system
were initially responsible for induction of Th2-type immune
responses and for parasite expulsion, now cause problems
with allergy-related diseases when living in “sterile” and
modern societies.
2.3. Helminth Infections that Promote Allergic Reactions. In
contrast to population studies reporting a negative correla-
tion between allergy and helminth infections as discussed
above,variousstudiesfromSouthAmerica,Europe,andAsia
on A. lumbricoides infections and allergy reported increased
rather than decreased prevalence of asthma [100–102]. For
example, two cross-sectional surveys among schoolchildren
in former East Germany revealed that children with low
dosesofhelminthicantigens(lowwormburden)butAscaris-
IgE seropositivity had higher levels of total IgE and higher
prevalence of allergic rhinitis and asthma to inhalant aller-
gens [101]. It was proposed that heavy parasitic infections
might generate immune suppressive mechanisms, whereas
mild worm exposure and low-level contact with helminths
may enhance reactivity to environmental allergens or even
potentiate the Th2 immune response that in some cases
may promote allergic inﬂammation. As Ascaris infection has
been well-documented as a risk factor for asthma (described
elsewhere [103–106]), there are two main hypotheses why
Ascaris promotes allergic reactions. The ﬁrst relates to the
speciﬁc pulmonary phase in the Ascaris life cycle that
causes inﬂammation and eosinophilia, which results in IgE-
mediated asthma with high total- and speciﬁc-IgE titres
againstlarvaeandadultworms[107].Thesecondhypothesis
of increased allergy in Ascaris infection is explained by cross-
reactivity of Ascaris-speciﬁc molecules with environmental
allergens like HDMs or the storage mites B. tropicalis that
induce allergen-speciﬁc IgEs leading to strong Th2-type
responses and therefore contributing to overall pathogen-
esis [108]. Moreover, Ascaris-tropomyosin, a pan allergen,
induced wheal and ﬂare in skin prick tests and histamine
release from basophils of asthmatics and nonasthmatics.
These results suggest that Ascaris-tropomyosin in some
allergic individuals potentiates the pathogenesis of asthma
and other allergic diseases [109–111].
Interestingly, the promotion of atopy can also be ob-
served in parasitic infections where the human is not
the deﬁnitive host and, therefore, chronic infection is6 Journal of Biomedicine and Biotechnology
not established, for example, Toxocara spp. [52, 112]. In
addition, the nematode Anisakis simplex, regularly infecting
marine mammals as deﬁnitive hosts but accidentally also
leading to gastrointestinal (GI) infections in humans, who
ingest raw ﬁsh, was described to cause allergic reactions.
Allergy to A. simplex is being recognised as an occupational
disease with a wide spectrum of allergic reactions (rhinitis,
asthma urticaria, allergic contact dermatitis, and anaphy-
lactic shock) [113–115]. As both parasites cause accidental
and infrequent infections, in case of infection the immune
system may be exposed to Th2-inducing events rather than
to immunomodulatory mechanisms that occur in chronic
infections. These may contribute to the immune pathology
a n dl e a dt oa l l e r g i cr e a c t i o n s .
It is important to keep in mind that variations in epide-
miological studies may have many confounding factors like
types of parasitic infections, intensity and timing of the in-
fection, other coinfections, ﬁrst exposure to allergen as com-
pared to parasitic infection, types of allergens, nutritional
status of the patients, medication received, and genetic back-
ground.
3.Host CellsTargetedby HelminthInfections
Current research has focused particularly on identifying the
cells targeted by parasitic immune modulation, and the exact
helminth-derived molecules responsible for this. Immune
modulation by the parasite occurs through production of
speciﬁc parasite-derived molecules that target mammalian
host immune cells and signaling pathways. During infection
this is strictly dependent on live parasites as shown by the
recovery of cellular hyporesponsiveness in patients treated
with anthelminthic chemotherapy [116]. In addition, a
study by Da’dara and Harn demonstrated that killing of
schistosome parasites could reinstate immune responses to a
bystandervaccinetargetinghumanimmunodeﬁciencyvirus-
1, which were greatly diminished in the presence of the para-
site [117]. Similarly, another study demonstrated that prior
elimination of intestinal helminths in patients vaccinated
with bacille Calmette-Guerin resulted in greater protective
responses to the vaccine compared with patients who
did not receive anthelminthic chemotherapy [118]. During
active infection, live worms are thus normally essential to
ensure constant release of immunomodulatory molecules.
Both GI and tissue-dwelling helminths can establish long-
term chronic infections and have many immunomodulatory
molecules in common, which, despite the diﬀerent anatom-
ical locations target similar host cells employing comparable
regulatory mechanisms. Thus, experimental models together
withhumanstudieshavehelpedtoelucidatethemechanisms
and cell targets underlying parasite-induced immune modu-
lation. In this section, we discuss some of the most common
and relevant examples.
3.1. Dendritic Cells. As professional antigen presenting
cells (APCs) required in priming the adaptive immune
response, dendritic cells (DCs) are an essential driving force
of Th2 induction in helminth infections and in allergy-
related diseases. The ﬁeld of research on DCs targeted by
parasite-induced immune modulation is as vast as that on
macrophages,andthereisdeﬁnitiveevidenceofaspeciﬁcDC
phenotype that develops in helminth infection, demonstrat-
ing modulation by the parasite to deviate host inﬂammatory
responses. Several groups could show that in helminth
infection, DCs mature only selectively or show impaired
functions in terms of TLR responsiveness [119–122]. As
DCs are the main messenger cells to communicate with
T cells and initiate an immune response, interference with
their functions represents a key mechanism for helminths to
induce an environment conducive to their survival [123].
The downregulation of proinﬂammatory cytokines ap-
pears to be a frequent feature in helminth-mediated modu-
lation of the Th2-type response [124]. Murine DCs stimu-
lated with lipids from S. mansoni eggs matured to induce
speciﬁcally Tregs that produced IL-10, reducing Th1 re-
sponses whilst producing a modulated Th2 response [19].
However, as reviewed by Carvalho et al. [124] DCs that
have been previously exposed to helminth products can also
eﬀectively prime Th2 cells. S. mansoni soluble egg antigen
(SEA) is a particularly strong inducer of Th2 responses, and
importantly the glycoprotein omega-1 was identiﬁed as the
main Th2-inducing component in SEA [23]. Human DCs
exposed to B. malayi mf showed higher levels of apoptosis
and decreased production of IL-12 and IL-10 [125]. In fact
when human monocytes that were being diﬀerentiated to
DCs in vitro were stimulated with B. malayi mf antigen,
they produced signiﬁcantly decreased levels of IL-12p40, IL-
12p70, and IL-10 in response to bacterial adjuvant [121].
Massacand et al. also demonstrated how DCs exposed to
excretory-secretory(ES)productsfrombothNippostrongylus
brasiliensis and Heligmosomoides polygyrus had reduced
expression of the proinﬂammatory cytokine IL-12/23p40
[126]. Similarly, Balic et al. reported that bone-marrow-
derived DCs exposed to N. brasiliensis ES (NES) products
actively matured and could induce a Th2 response when
transferred into na¨ ıve mice [119]. High levels of IL-4, IL-5,
and IL-10 were detected after reexposure to NES. In vitro,
these DCs produced high levels of IL-6 and IL-12p40 but full
production of IL-12p70 was blocked. Finally it was shown
that murine lipopolysaccharide- (LPS-) or CpG-matured
DCs exposed to ES products from Taenia crassiceps showed
diminished responses to stimulation through TLRs 4 and 9.
These DCs signiﬁcantly decreased levels of proinﬂammatory
cytokines, including IL-12p40 and IL-12p70, as well as TNF-
α and IL-15. IL-10 was, however not aﬀected in this study
[127]. Thus, downregulation of proinﬂammatory cytokines
seems to be a frequent mechanism in immune modulation
by helminths.
Combined with suppression of proinﬂammatory cytok-
ines, a key aspect in modulation of DCs is the downregu-
lation of costimulatory molecules, leading to induction of a
Th2 response [124]. Dowling et al. illustrated that stimula-
tion of murine bone-marrow-derived DCs with A. lum-
bricoides pseudocoelomic body ﬂuid (ABF) inﬂuenced DC
maturation by inducing expression of IL-6, IL-12p40, and
macrophage inﬂammatory protein 2. However, DC matu-
ration was only partial as levels of costimulatory molecules
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c o m p l e x( M H C )c l a s sI Iw e r en o ta ﬀected. Furthermore,
when DCs were cultured in the presence of ovalbumin
(OVA) with ABF and then transferred into na¨ ıve mice,
restimulation resulted in signiﬁcantly increased levels of IL-
4, IL-5, and IL-10 compared to DCs cultured without ABF
[128]. Coculturing of ES products but not adult worm
antigen from H. polygyrus with LPS-treated DCs induced a
semimature phenotype with moderate expression of CD40,
CD86, and MHC class II [120]. In fact when DCs were
treated with ES and OVA and subsequently cultured with
OVA-speciﬁc T cells, the T cells developed a regulatory
phenotype, expressing CD25 and high levels of IL-10 [120].
Thus, targeted DCs could suppress both Th1 and Th2
responses. Furthermore, a novel subset of DCs expressing
low levels of CD11c have also recently been identiﬁed in
mice chronically infected with H. polygyrus [129]. In this
infection setting, DCs acted as eﬃcient APCs and induced
high numbers of CD4+ T cells expressing Foxp3 but only low
numbers of CD4+ eﬀector T cells. This population of DCs
was suggested to be one of the main target cells involved in
inducing an immunoregulatory environment in H. polygyrus
infection, allowing the establishment of chronic infection
[129]. Nevertheless, DCs are clearly essential for eﬃcient
priming of the Th2 response, as depletion of CD11c+ cells
during development of the adaptive CD4+ Tc e l lr e s p o n s ei n
S. mansoni infection drastically impaired the Th2 response
[130].
3.2. Alternatively Activated Macrophages. Macrophages that
are activated by the Th2-type cytokines IL-4 and IL-13
developanalternativelyactivatedphenotypeandhaveawell-
described role in helminth infections (reviewed by Hoerauf
etal.[131]).Alternativelyactivatedmacrophages(AAMs)are
recruited in large numbers to the sites of helminth infection
where they can proliferate, as recently shown [4]. AAMs
are characterised in mice by expression of speciﬁc markers,
including arginase-1, resistin-like molecule (RELM)-α (also
known as found in inﬂammatory zone, FIZZ1), Ym-1, Ym-
2, acidic mammalian chitinase (AMCase), and mannose
receptor C type (MRC)-1 [132]. AAMs are important in
tissue homeostasis, downregulation of the adaptive immune
system,actingaseﬀectorcellsagainstparasites,andtoreduce
or heal any ensuing damage caused by infection [133]. In
particular, AAM-derived arginase-1 is important for wound
healing [134]. AAMs recruited during B. malayi infection
have been demonstrated to drive CD4+ Th2 responses,
deviating the immune system from inducing a proinﬂam-
matory Th1 response that could be detrimental to parasite
survival [135]. Monocytes from B. malayi asymptomatically
infected patients have also been described to show an
alternatively activated phenotype, expressing the AAM-
speciﬁc markers arginase-1, MRC-1, resistin, and CCL18 as
well as the downregulatory cytokines transforming growth
factor (TGF)-β and IL-10 [136] (similar to what has been
described for mouse AAMs [137]). However, translation of
characterised markers into the human system in general
should be done with caution, as reports indicate arginase-
1 may not be a reliable marker for AAMs in humans as
it is found in other cell types [138]. Furthermore, human
monocytes do not express arginase-1 after stimulation with
IL-4 and IL-13, unlike mouse macrophages (reviewed by
Raes et al. [139]). This indicates that the translation from
murine to human data can be diﬃcult, and reliable markers
for alternative activation in human monocytes should be
further investigated.
The importance of AAMs is clear from numerous mouse
models. Macrophages from B. malayi infected mice were
shown to be fully capable of processing and presenting anti-
gen and providing costimulation for T cells, however the re-
sulting antigen-speciﬁc T cell population remained subop-
timal with cell proliferation but not Th2 cell cytokine pro-
duction being impaired [140]. These macrophages were IL-
4-dependent and required direct contact with T cells to
induce hyporesponsiveness [141]. In a mouse model of S.
mansoni infection, arginase-expressing macrophages played
an essential role in host protection by suppressing expres-
sion of the classical inﬂammatory cytokines IL-12 and IL-
23 [142]. Removal of these cells resulted in an accumulation
of parasite eggs in the intestines and intestinal haemorrhage,
thus preventing the eggs from being excreted. Slightly
diﬀerent eﬀector functions of AAMs come into play in
GI helminth infections. Large numbers of AAMs were
shown to accumulate in N. brasiliensis infection in the
gut, characterised by expression of arginase-1, RELM-α
and Ym-1, in an IL-4- and IL-13-dependent manner [143].
Macrophage depletion resulted in impaired worm expulsion
from the small intestine and prevented smooth muscle
hypercontractility.
RELM-α in particular has a clear immunomodulatory
role during infection. RELM-α was shown to be essential in
regulating lung inﬂammation, granuloma size and ﬁbrosis
in mice challenged with S. mansoni eggs [144]. Addition-
ally,RELM-αdeﬁcientmicecouldnotcontrolTh2celldiﬀer-
entiationorcytokineproduction.Moreover,Pesceetal.illus-
trated that challenge of RELM-α deﬁcient mice with S. man-
soni eggs resulted in elevated eosinophil levels and IgE titres.
In the same study RELM-α deﬁcient mice challenged with
N. brasiliensis infection produced increased Th2 responses,
manifested by elevated lung pathology and expulsion of
adult worms. Importantly, addition of exogenous RELM-α
reversed the pathological Th2 responses in this infection
[145]. This represents RELM-α as a key host-derived mol-
ecule induced by helminth infection to allow prolonged
parasite survival. These studies point at a host protective
role for AAMs in speciﬁc tissue dwelling and GI helminth
infections.
3.3. Regulatory T Cells. Among the cell types targeted during
helminth infections, CD4+ Tregs are particularly implicated
in controlling innate and adaptive immunity. Natural CD4+
Tregs develop in the thymus and express the transcription
factor Foxp3, the IL-2 receptor α chain (CD25), CTLA-4,
and a range of immunosuppressive proteins including IL-10
and TGF-β [146]. Additionally, other adaptive CD25+ Treg
populations exist in the periphery that develop from non-
regulatory T cell subsets, with their expression of IL-10
and TGF-β distinguishing them from activated CD4+CD25+
nonregulatory T cells. Tregs are important in reducing8 Journal of Biomedicine and Biotechnology
pathology in the host via suppression of both Th1 and Th2
responses, thus preventing disease symptoms as demonstrat-
ed by evidence of Treg involvement in both Th2-mediated
allergies and Th1-mediated autoimmunity (reviewed by Else
[147]). In a murine model of schistosomiasis CD4+CD25+
T cells expressing high quantities of IL-10 were shown to
play a signiﬁcant role in reducing immunopathology, es-
pecially in the chronic stage of infection [148]. McKee
and Pearce illustrated that in S. mansoni-infected mice
CD4+CD25+Foxp3+ cellsproducedsigniﬁcantlevelsofIL-10
thatwererequiredtopreventDC-derivedIL-12,therebysup-
pressing Th1 responses [149]. In fact, isolated schistosome
eggs were demonstrated to be capable of modulating Th2
responses, without the need for the former life cycle stages
that develop during infection. Schistosome eggs injected
into mice were shown to induce a population of Foxp3+
cells that expanded to control the CD4+ T cell response,
preventing inﬂammatory Th1 responses while modulating
Th2 responses to prevent Th2-mediated immunopathology
[150]. Both natural and adaptive Tregs have been described
inﬁlarial-infectedpersons,withtheadaptiveTregpopulation
producing high levels of IL-10 [151]. Our group has
shown that in H. polygyrus infection, Foxp3+ Tregs are a
requirement for limiting immunopathology and represent
a potential source of IL-10 [152, 153]. Thus, while Treg
depletiondidnotaﬀectwormburdens,theTh2responsewas
greatly accelerated and augmented, with high levels of IL-4
and IL-13 being produced. The uncontrolled Th2 response
led to increased immunopathology in the intestine, demon-
strating that Tregs were essential in regulating this response
[153]. Foxp3+ Tregs were also induced after stimulation
with H. polygyrus ES products, reducing proliferation of
eﬀector cells by activating the TGF-β signaling pathway [82].
During infection, Tregs may therefore be seen as important
eﬀector cells required to prevent or reduce pathology in
the host by modulating the ensuing Th2 response, thereby
simultaneously allowing establishment of chronic infection.
3.4. B Cells. Host protection as well as regulation by
antibodies and B cells is being recognised as an essential
componentinTh2responsesinhelminthinfections[154].In
S. mansoni-infected mice, where the dominant isotypes are
IgG1 and IgE [154], blockade of B cell production resulted
in high levels of the proinﬂammatory cytokines IFN-γ and
IL-12 but low levels of the Th2 cytokines IL-4 and IL-10
in acute infection [155]. Moreover mice deﬁcient in B cells
could not downregulate granuloma formation in the chronic
stage of infection, and this mechanism was mediated by
FcγR, indicating a role for antibodies in down modulation of
pathology [156]. In fact, antibody isotypes are demonstrated
to have an important role in determining the outcome of
helminth infection in the host. The cytokines IL-4 and IL-
13 act on B cells to induce both IgG1 and IgE in mice and
IgG4andIgEinhumans.HighlevelsofIgG4butlowlevelsof
IgE are found in the blood of hyporesponsive, asymptomatic
persons infected with B. malayi, W. bancrofti, and O. volvulus
[16, 157]. IgG4 correlates with high levels of IL-10 and
the presence of adult worms in hyporesponsive persons.
In Bancroftian ﬁlariasis, high levels of IgG4 [158] but low
levels of IgE [159] were found in mf positive individuals
compared to patients with clinical disease (elephantiasis or
tropical pulmonary eosinophilia). IgE is known to activate
degranulationofmastcells(MCs),basophilsandeosinophils
and induce antibody-dependent cell-mediated cytoxicity
(ADCC) [154, 160]. IgG1 in mice and IgG4 in humans
compete with IgE for binding sites and therefore may inhibit
such processes. In fact, IgG4 has downstream suppressive
eﬀects, such as inhibiting complement activation [161].
Thus, inhibitory IgG4 may prevent immunopathological
responses in helminth asymptomatically infected individuals
and can simultaneously provide an indication of the clinical
outcome in infected persons.
Regulatory B cells have been ﬁrst described in autoim-
mune diseases, where the main mediator of suppres-
sion is IL-10 [154]. Helminth infections can also induce
speciﬁc B cell phenotypes with regulatory properties
as shown in infection with S. mansoni and H. poly-
gyrus [162]. In S. mansoni infection, a particular sub-
set of B cells has been described that are CD1dhigh
and express high levels of IL-10 (deﬁned as CD19+IL-
10+CD1dhighCD5+CD21highCD23+IgD+IgMhighcells). Trans-
fer of these cells into OVA-sensitized mice reduced OVA-
induced allergic airway inﬂammation via induction of
Foxp3+ Tregs; the eﬀect was TGF-β independent as showed
in anti-TGF-β mAb treatment experiments [163]. Further-
more, another group demonstrated that transfer of IL-10-
producing B cells from IL-4 deﬁcient mice infected with
S. mansoni provided complete resistance to experimentally
induced anaphylaxis when applied to na¨ ıve mice. Thus,
absence of IL-4 was essential to prevent exacerbation of this
allergic response [73]. In another study, the same group
proved that the protective response of S. mansoni infection
was entirely dependent on B cells as depletion of IgM+
B cells resulted in mice becoming completely susceptible
to anaphylaxis [74]. Interestingly, adoptive transfer of a
population of CD19+CD23high Bc e l l sf r o mH. polygyrus-
infected mice could reduce the eﬀects of allergic airway
inﬂammation of OVA-sensitized mice, however, in an IL-10
independent manner. These mesenteric lymph node B cells
reduced secretion of IL-5 and inﬁltration of eosinophils into
the airways, suppressing allergen-induced pathology [80].
Thus, B cells from helminth infections exhibit regulatory
capacity in unrelated diseases and are of therapeutic interest
in allergies, therefore their phenotype and functional aspects
should be further investigated.
4. Immunomodulatory Effects of
Helminth-DerivedMolecules andTheir Role
inModulationof Allergy-RelatedDiseases
Therearenumerousstudiesexaminingtheeﬀectsofdiﬀerent
helminth infections (e.g., S. mansoni [73–75], H. polygyrus
[78,81,164],N.brasiliensis [83],Trichinellaspiralis[87],and
Litomosoides sigmodontis [88]) on allergy-related diseases
in experimental animal models, where helminths show the
capacity to suppress abberrant Th2 immune responses. In
addition, ES products either from H. polygyrus [82]o rJournal of Biomedicine and Biotechnology 9
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Figure 1:RegulatoryandeﬀectormechanismsofTh2-typeresponses.Th2immuneresponseinhelminthinfection:helminthinfectioninduces
a protective Th2 immune response. Professional antigen presenting cells such as dendritic cells (DCs) process helminth antigens and display
them to CD4+ Tc e l l st h a td i ﬀerentiate into polarised T helper 2 cells. Th2 cells produce cytokines such as IL-4, -5, and -13 that activate and
attract macrophages, eosinophils, and other innate immune cells as well as B cells. IL-4 and -13 induce diﬀerentiation of antigen-speciﬁc
B cells and production of large amounts of antibodies (characteristically IgE). Antibodies opsonise the helminths leading to killing via
eosinophils or neutrophils, as well as macrophages by antibody-dependent cellular toxicity (ADCC). IgEs bind to Fcε-receptors (FcεRI) on
mast cells (MCs). Sensitized MCs secrete large amounts of histamine and other mediators and facilitate the attraction and accumulation
of further immune cells, which result in larvae killing. Regulatory mechanisms in helminth infection: Helminths induce immunoregulation
via modulation of immune cells leading to alternatively activated macrophages (AAMs), regulatory T cells (Treg), and B cells. AAMs in
mice express among others arginase-1 (Arg 1), resistin-like molecule-α (RELM-α), Ym-1, Ym-2, IL-10, and TGF-β and contribute to
wound healing. Treg produce IL-10 and transforming growth factor-β (TGF-β), whereas B cells can elicit regulatory mechanisms via IL-
10. These cellular changes lead to modiﬁed Th2 immune responses and larvae survival as well as blocking of unrelated inﬂammation such
as allergic immune responses. Allergic inﬂammation: DCs present allergen-derived peptides to T cells. Stimulation of allergen-speciﬁc T cells
results in diﬀerentiation of CD4+ T cells into Th2 cells that produce Th2 cytokines. IL-4 directs T cell diﬀerentiation towards a Th2-related
phenotype. IL-5 regulates the recruitment and diﬀerentiation of eosinophils and stimulates them to release mediators. Additionally, IL-4
and -13 induce Ig-class switching to IgE by B cells. IgEs bind to high aﬃnity FcεRI on MCs. Sensitized, IL-9-activated, and maturated MCs
degranulate and release preformed mediators, including histamine, leukotrienes, and prostaglandins. This allergic inﬂammatory cascade
leads to increased mucus production, eosinophilia, bronchoconstriction, smooth-muscle contraction, and remodelling in the lungs, which
resultinallergic-airwayhyperreactivity(AHR),airwayinﬂammationorasthma.Theallergicinﬂammationmaybesuppressedbyaspill-over
eﬀect of immunomodulatory mechanisms of helminth infections.
N. brasiliensis [84] were described to have similar beneﬁ-
cial immunoregulatory eﬀects. Furthermore, helminths act
through various cell types and can interfere with allergy
symptoms in animal models via distinct mechanisms includ-
ing Tregs [79, 82, 88] ,Bc e l l s[ 73, 80, 163], and induction
of regulatory cytokines like IL-10 [78, 81, 83, 87]o rT G F -
β [87, 88, 163], as discussed in the previous section and
reviewed in Table 2.
These and other studies led to the discovery of spe-
ciﬁc immunomodulatory helminth-derived molecules and
products that induce a microenvironment beneﬁcial to the
parasite, while at the same time preventing immune-related
pathologyassociatedwithvigorousTh2responses(Figure 1).
However, as mentioned earlier, persistence of the parasite
is not obligatory to reduce allergic symptoms in later life
[63]. Moreover, these functionally and structurally diverse
molecules are expressed throughout the parasite life cycle
andinteractdirectlywithhostcells.Asummaryofhelminth-
derivedimmunomodulatorymoleculesandproductsisgiven
in Table 1. We focus here on molecules that are relevant for10 Journal of Biomedicine and Biotechnology
human disease, established animal models of host-parasite
interactions, and deﬁned molecules that downregulate unre-
lated Th2 inﬂammation.
4.1. Homologues of Mammalian Cytokines and Chemokines.
The existence of parasite-derived homologues of host mam-
malian anti-inﬂammatory cytokines reveals an apparent
evolutionary struggle between the parasite and the host,
whereby the parasite has evolved mechanisms to establish
chronic infection. For example, two TGF-β homologues
found in Brugia species, Bm-tgh-1 and Bm-tgh-2,h a v eb e e n
well characterised, the second of which is thought to have
an immunomodulatory role. TGH-2 is secreted by adult
worms and in its recombinant form was shown to bind the
human TGF-β receptor, thus potentially inﬂuencing Treg
development [43, 165]. S. mansoni male worms express a
member of the TGF-β receptor family known as SmRK-1
[166] for which mammalian TGF-β may be a ligand involved
in worm development [167]. H. polygyrus ES contains
remarkable TGF-β-like activity, inducing Foxp3 expression
in na¨ ıve T cells and modulating immune functions, thereby
maintaining worm burdens to induce chronic infection [82].
The beneﬁcial role of homologues of mammalian
chemokines such as macrophage migration inhibitory fac-
tor (MIF) is less apparent. MIF homologues have been
described in multiple helminth species (reviewed elsewhere
[168, 169]). Mammalian MIF has numerous functions, in
particular as a proinﬂammatory cytokine [169]. Helminth
MIF has direct chemotactic eﬀects on human monocytes but
appears to be associated with anti-inﬂammatory, modiﬁed
Th2-type responses [170]. In a murine model of asthma,
a recombinant MIF-like protein from A. simplex (As-MIF)
was described to have a protective eﬀect and to suppress the
Th2-type response, reduce production of IL-4, -5 and -13 in
the bronchoalveolar lavage ﬂuid (BAL), inhibit eosinophilia,
goblet cell hyperplasia, and ameliorate lung hyperreactivity.
The eﬀect of As-MIF was possibly mediated by IL-10 and
TGF-β production in the BAL as well as via Treg induction
in the lungs of As-MIF-treated animals when compared to
asthmatic controls [66].
Another helminth-derived molecule with structural sim-
ilarities to mammalian chemokines is Ancylostoma-secreted
protein-2 (Na-ASP-2) secreted by the infective larvae of
Necator americanus hookworm. Recombinant Na-ASP-2
was shown to recruit high numbers of neutrophils when
injected into an air pouch (a sterile inﬂammatory setting)
in mice. The inﬂux of neutrophils was suggested to create
permeability in host vessels, thus facilitating larval migration
[29]. Hence, cytokine homologues seem to be exploited by
the parasite for eﬃcient immune evasion; however more
work is needed to assess which of those molecules participate
in suppression of unrelated inﬂammation.
4.2. Protease Inhibitors. The cystatins and serpins are the
best-characterised protease inhibitors of helminths that have
immunomodulatory potential. Mammalian cysteine pro-
teases are essential for eﬃcient processing and presentation
ofantigenonMHCclassIItoinduceanappropriateadaptive
Tcellresponse.Mammaliancystatinsplayavitalroleinregu-
lating these pathways; however, helminth cystatins from
Acanthocheilonema viteae, B. malayi, N. brasiliensis,a n d
O. volvulus have been shown to interfere with this process
to dampen antigen-dependent immune reactions (reviewed
by Klotz et al. [171]). Bm-CPI-2, a cystatin from B. malayi,
was illustrated to interfere with antigen processing, which
l e dt oar e d u c e dn u m b e ro fe p i t o p e sp r e s e n t e dt oT
cells in vitro [41]. Studies from our own group have
demonstrated that onchocystatin (rOv17) from O. Volvu-
lus reduced antigen-driven proliferation of peripheral blood
mononuclear cells in a monocyte-dependent manner [45].
Recombinant AvCystatin (rAv17) from A. viteae has potent
immunomodulatory roles illustrated by its ability to reduce
antigen-speciﬁc and unspeciﬁc T cell responses [34]. AvCys-
tatin is recognised by macrophages and upon uptake induces
phosphorylation of the mitogen-activated protein kinase
signaling pathways ERK1/2 and p38 in macrophages. This
ledtotyrosinekinase-dependentIL-10productioninmacro-
phages [34, 35]. Furthermore, we could show in an OVA-
induced airway hyperreactivity mouse model that AvCystat-
in-treated asthmatic mice exhibited amelioration of the dis-
ease. AvCystatin administered intraperitoneally (i.p.) during
the sensitization phase as well as before challenge with OVA,
suppressed recruitment of eosinophils into the lungs, OVA-
speciﬁc and total IgE levels, and reduced allergen-speciﬁc IL-
4 production. IL-10 is a key element in AvCystatin-induced
immunomodulation, as blocking of IL-10 with an anti-
IL-10R mAb reversed the beneﬁcial eﬀect on cell recruit-
mentandproductionofIgE[71].Moreover,depletionofma-
crophages with clodronate liposomes before airway allergen
challenge diminished the antiallergic eﬀect of AvCystatin
[71].
The rodent ﬁlarial species L. sigmodontis secretes a cys-
tatin at various stages of the life cycle, which after injec-
tion via microosmotic pumps into the peritoneal cavity of
L. sigmodontis-infected mice greatly decreased nitric oxide
production and proliferation of antigen-speciﬁc spleen cells
[44].
Similarly, recombinant cystatin from the ES product
of the GI nematode N. brasiliensis (named nippocystatin,
NbCys) was shown to inhibit cathepsins L and B, and
suppressed antigen processing by APCs [172]. Furthermore,
OVA-sensitized and NbCys-treated mice showed decreased
OVA-speciﬁc spleen cell proliferation, reduced OVA-speciﬁc
IgE levels and cytokine production due to inhibition of
cathepsin B and L-dependent antigen processing [70].
Similar to cystatins, serpins (serine protease inhibitors)
have important roles in mammalian biological processes
including regulation of complement activation, inﬂamma-
tory pathways, and cell interactions. Bm-SPN-2 is a serpin
expressed by B. malayi microﬁlariae, which could inhibit
proteasesofhumanneutrophils,therebyinterferingwithand
potentially circumventing the most abundant leukocyte to
encounter mf in the bloodstream [173]. However, another
study by Stanley and Stein contests the enzymatic activity
of Bm-SPN-2 [174]. Thus, further studies should clarify
the role of serpins as immunomodulatory molecules. Taken
together, protease inhibitors such as cystatins are a class ofJournal of Biomedicine and Biotechnology 11
moleculesfoundinnumeroushelminthsthathaveimportant
immunomodulatory functions.
4.3. ES-62. A secreted 62kDa glycoprotein from A. viteae
known as ES-62 is one of the best-characterised helminth
immunomodulators. ES-62 has been shown to exhibit a
plethora of well-documented anti-inﬂammatory properties
[175] and contains phosphorylcholine moieties, which are
largely responsible for immunomodulation (reviewed by
H a r n e t te ta l .[ 176]). OVA-speciﬁc CD4+ T cells exhibited
lower levels of proliferation and IL-2 production after
challenge with ES-62, as well as inhibition of IL-4 and IL-
13 [36]. It was also shown that ES-62 acts on macrophages
to inhibit production of IL-12 if the cells were subsequently
exposed to LPS and IFN-γ [37, 38]. ES-62 could also be
shown to act on bone-marrow-derived precursors of DCs
to inhibit a proinﬂammatory response induced by LPS [39]
and B cells by modulating T and B cell interactions [177].
ES-62 is also active against FcεRI-mediated MC responses in
vitro. It directly inhibited FcεRI-induced release of allergy
mediators from human MCs by selectively blocking key
signal transduction events. ES-62 also interfered with MCs
in vivo in a mouse model of immediate-type hypersensi-
tivity to oxazolone, thereby diminishing ear swelling and
MC-dependent hypersensitivity, as well as ex vivo MC
degranulation in mice that were previously injected with
the molecule. Moreover, ES-62 ameliorated OVA-induced
murine airway inﬂammation, airway hyperresponsiveness,
lung pathology, and eosinophilia by suppression of MC
function [72]. Thus, ES-62 is likely to be a key mediator of
ﬁlarial-induced immunoregulation, and its properties might
beusedtodampenoverwhelmingunrelatedinﬂammationin
the future.
4.4. Schistosome-Derived Antigens. Schistosome soluble egg
antigen (SEA) and ES products released by the egg stage of
the parasite contain potent Th2-inducing and immunomod-
ulatory activity. SEA from S. mansoni was shown to be an
extremely strong inducer of Th2 responses without the need
for live infection or the addition of adjuvant [178]. Recently
it was shown that omega-1, a hepatotoxic ribonuclease, is
one of the key players in this response [23, 24]. Omega-
1 is a glycoprotein, which was demonstrated to polarise
human monocyte-derived and CD11c+ murine DCs in a
direction supporting Th2 responses even in the presence
of LPS. In fact, SEA depleted of omega-1 was not able to
suﬃciently induce a Th2 response in vitro [24]. However,
the Th2-suppressive actions of schistosome-derived antigens
clearly highlight the ability of this helminth to modulate host
immune responses. ES- or omega-1-treated DCs display the
typical modulated phenotype that is critical for induction of
a Th2 response, including reduced expression of costimula-
tory molecules and a lowered eﬃciency in participating in
DC-T cell conjugates [23]. In fact, this study demonstrated
that omega-1 was shown to alter the morphology of
DCs, possibly preventing T cell activation. IPSE/alpha-1 is
another glycoprotein present in SEA and abundant in ES,
which could induce IL-4 production from human basophils
in an IgE-dependent but antigen-independent mechanism
[179]. S. mansoni also expresses glycans that have been
shown to exhibit immunomodulatory functions. Okano et
al. demonstrated that glycan-containing SEA could induce
high levels of IL-5, IgE production, and eosinophilia when
administered intranasally into mice [178] .T h es a m eg r o u p
wassubsequentlyabletoshowthatS.mansoniSEAcontained
the carbohydrate lacto-N-fucopentaose III (LNFPIII), which
induced high levels of IL-4, IL-5, and IL-10 by nasal
lymphocytes bypassing the need for an adjuvant [180].
DCs are also targeted by lyso-phosphatidylserine (Lyso-PS)
present in SEA, to dampen the Th2 response. Lyso-PS was
shown to act on DCs via the TLR2 pathway, endowing them
with the ability to induce IL-10-producing Treg cells [19].
Whole SEA, as well as SEA-derived molecules, has
been described to interfere with animal models of allergy-
related diseases. Yang et al. used S. japonicum SEA to
test its eﬀect in experimentally induced asthma in mice.
SEA increased IL-10 production and expression of Foxp3
on CD4+CD25+ T cells, both with immunosuppressive
activity, while at the same time decreasing the expression of
Th2 (IL-4 and IL-5) cytokines, suppressed antigen-induced
airway inﬂammation, recruitment of inﬂammatory cells into
the lungs, and development of asthma [76]. S. mansoni
egg-secreted chemokine-binding protein (smCKBP) was
reported to signiﬁcantly diminish ear swelling of hapten-
sensitized mice in a contact hypersensitivity model. Isolation
of the inﬂammatory inﬁltrate from hapten-treated ears of
smCKBP-treated mice showed reduction of neutrophilia
when compared to cells isolated from the ears of control
animals. Smith et al. showed that smCKBP has speciﬁc in
vivo activity, suppressing immediate or local inﬂammation
[27].Additionally, threeS.mansoniantigens Sm22.6 (soluble
protein associated with the S. mansoni tegument), PIII
(a multivalent antigen of S. mansoni adult worms), and
Sm29 (a membrane bound glycoprotein on the S. mansoni
adult worm tegument) were evaluated in the OVA-induced
airway inﬂammation mouse model. All three antigens
showed a beneﬁcial immunomodulatory eﬀect in this allergy
model characterised by suppression of airway inﬂammation,
reduced eosinophilia in the lungs, decreased OVA-speciﬁc
IgE levels, and lower Th2-speciﬁc cytokine production in
BAL when compared to asthmatic animals. Sm22.6 signif-
icantly induced higher levels of IL-10, while both Sm22.6
and PIII lead to increased expression of CD4+Foxp3+ T
cells suggesting that Treg cells might be involved in the
modulation of this aberrant Th2 inﬂammation [65].
4.5. Molecules of Ascaris suum . Although Ascaris infections
are described to support allergic inﬂammation (Section 2.3),
products from A. suum have also been described to con-
tain immunomodulatory activity, in particular the 200kDa
protein PAS-1. Administration of PAS-1 to mice that had
been injected with LPS into sterile air pouches resulted in
a signiﬁcant decrease in neutrophil migration as well as
suppressingproinﬂammatorycytokinesIL-6,TNF-α,andIL-
1β [28]. In particular, signiﬁcant eﬀects of PAS-1 have been
demonstrated in allergy. Itami et al. [67] used a murine
model of asthma induced by another A. suum-molecule,
APAS-3 that promotes IgE production [181], to test the12 Journal of Biomedicine and Biotechnology
suppressive eﬀectof PAS-1 [182]. In this experimental model
of asthma induced by APAS-3, PAS-1-treated mice showed
decreased eosinophil migration into the lungs, lower IL-4,
IL-5, CCL11 and RANTES production in the BAL, as well as
reduced airway hyperreactivity. Moreover, IL-10 production
was considerably increased after PAS-1 treatment when
compared to APAS-3-immunized controls. Thus, A. suum
has allergenic components as well as suppressive products
that downregulate allergic responses [67]. More recently, a
studyfromthesamegroupshowedsuppressiveeﬀectofPAS-
1 also in OVA-induced airway inﬂammation. In line with
previous ﬁndings, PAS-1 reduced eosinophilia, decreased
production of Th2 associated cytokines in the BAL and
OVA-speciﬁc IgE and IgG1 levels in serum. Moreover, the
eﬀect was observed in IL-12- but not in IL-10- and IFN-
γ-deﬁcient animals, thus IL-10 and IFN-γ played a role in
the immunomodulatory eﬀect of PAS-1 [68]. Furthermore,
the authors reported that the immunomodulatory eﬀect of
PAS-1 was mediated by CD4+CD25+ and CD8+ Tc e l l sa s
shown by adoptive cell-transfer into OVA-sensitized and
challenged mice. Recipients of PAS-1-primed CD4+CD25+ T
cells had increased levels of IL-10/TGF-β whereas mice with
transferred PAS-1-primed CD8+ T cells showed prominent
IFN-γ production[69].Thosethreecytokinesweredescribed
to play important roles in the suppression of allergic diseases
and reported to be strongly induced during successful
allergen-speciﬁc immunotherapy in humans as reviewed by
Holgate and Polosa [183].
5. Conclusion
Helminths have had millions of years to evolve regulatory
mechanisms that circumvent the mammalian immune re-
sponseandallowforthelongevitycharacteristicallyobserved
duringinfection.Thus,understandingofthiscoevolutionary
nature is important in order to comprehend the iimmun-
omodulatory potential of helminth-derived molecules. This
will better allow the development of therapeutical targets
in symptomatic disease in helminth infections and help to
break transmission of infection in endemic countries. Fur-
thermore, the genetic basis underlying diﬀerences in re-
sponses of diﬀerent individuals to helminth infections
should be examined to develop a full understanding of these
parasites, and current studies are beginning to address this.
Inparticular,relevantexperimentalmodelsforﬁlarialdisease
are required to study both asymptomatic and pathological
responses.
The connection between helminth infections and allergy
is of particular interest. The epidemiological data reported in
this paper together with experimental studies clearly support
the view of the immunomodulatory potential of helminth-
derived products to interfere with and even prevent aberrant
allergic inﬂammation. These interactions are summarised in
Figure 1.
Research should focus on studying the immunomodu-
latory eﬀects of helminth-derived products on allergy and
strive to develop new therapeutic strategies by identifying
the mechanisms and pathways utilised by such molecules in
mediating their immunomodulatory eﬀects.
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